ID: ALA5271146

Max Phase: Preclinical

Molecular Formula: C15H14ClN5O7

Molecular Weight: 411.76

Associated Items:

Representations

Canonical SMILES:  CC(=O)Nc1nc(Cl)c2ncn(C3O[C@H]4[C@H](OC(=O)[C@@H]4O)[C@H]3OC(C)=O)c2n1

Standard InChI:  InChI=1S/C15H14ClN5O7/c1-4(22)18-15-19-11(16)6-12(20-15)21(3-17-6)13-10(26-5(2)23)9-8(27-13)7(24)14(25)28-9/h3,7-10,13,24H,1-2H3,(H,18,19,20,22)/t7-,8-,9+,10-,13?/m1/s1

Standard InChI Key:  HSWZGMYYPNYJGP-FSNIXKBVSA-N

Associated Targets(Human)

Acetylcholinesterase 18204 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Butyrylcholinesterase 7174 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 411.76Molecular Weight (Monoisotopic): 411.0582AlogP: -0.45#Rotatable Bonds: 3
Polar Surface Area: 154.76Molecular Species: NEUTRALHBA: 11HBD: 2
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.92CX Basic pKa: CX LogP: -0.32CX LogD: -0.32
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.50Np Likeness Score: 0.74

References

1. Lopes JPB, Silva L, Lüdtke DS..  (2021)  An overview on the synthesis of carbohydrate-based molecules with biological activity related to neurodegenerative diseases.,  12  (12.0): [PMID:35028560] [10.1039/D1MD00217A]

Source